scholarly article | Q13442814 |
P2093 | author name string | I Alam | |
B Cecil | |||
K D Kistler | |||
T Stainbrook | |||
P2860 | cites work | Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence | Q43270283 |
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival | Q42990049 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ribavirin | Q421862 |
P304 | page(s) | 535-542 | |
P577 | publication date | 2010-05-25 | |
P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
P1476 | title | Enhanced adherence to HCV therapy with higher dose ribavirin formulation: final analyses from the ADHERE registry. | |
P478 | volume | 32 |
Q93048181 | A Randomized Controlled Trial to Assess the Impact of Clinical Pharmacy Interventions on Treatment Outcomes, Health Related Quality of Life and Medication Adherence Among Hepatitis C Patients |
Q34506193 | Adherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of patient-reported facilitators and barriers |
Q36990416 | Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence |
Q36496953 | Anemia management in the era of triple combination therapy for chronic HCV. |
Q36418455 | Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute? |
Q36079814 | Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. |
Q36285092 | Health state utilities associated with attributes of treatments for hepatitis C. |
Q36120739 | Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial |
Q33774344 | Self-efficacy and adherence to antiviral treatment for chronic hepatitis C. |
Search more.